Aclaris Therapeutics, Inc. (ACRS)
Market Open
12 Jun, 17:55
$
4. 39
+0.02
+0.5721%
$
494.44M Market Cap
- P/E Ratio
- Div Yield
274,976 Volume
-1.64 Eps
$ 4.37
Previous Close 
Want to track ACRS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Aclaris Therapeutics, Inc. (ACRS) Statistics
Valuation metrics
Market Cap 494.44M
Enterprise value 499.12M
Trailing P/E (ttm) -8.06
Forward P/E -5.73
PEG ratio -0.15
Price/Sales (ttm) 62.84
Price/Book (mrq) 3.91
Enterprise Value/Revenue 59.65
Enterprise Value/EBITDA -6.83
Overview
Shares outstanding 120.5M
Float 83.07M
Shares short 7.02M
% Held by insiders 0.03%
% Held by institutions 0.84%
Average volume (10 days) 802.98K
Average volume (90 days) 1.81M
Price summary
52-Week low 1.34
52-Week high 5.15
Beta 0.68
50-Day moving average 4.54
200-Day moving average 3.57
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -8.33%
Operating margin -9.62%
Operational effectiveness
Return on assets -0.35%
Return on equity -0.56%
Income Statement
Revenue (ttm) 7.83M
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -0.86%
Gross profit (ttm) -52.1M
EBITDA -74.03M
Net income to common (ttm) -64.92M
Diluted EPS (ttm) -0.54
Quarterly earnings growth (yoy) -0.86%
Balance Sheet
Total cash (mrq) 90.75M
Total cash per share (mrq) 0.82
Total debt (mrq) 2.12M
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.03%
Book value per share (mrq) 1.12
Cash Flow
Cash flow statement -47.11M
Levered free cash flow (LFCF) -30.63M
